Pediatrix director granted 472 restricted shares

Rucker Michael A. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Rucker Michael A. reported acquisition or exercise transactions in this Form 4 filing.

Pediatrix Medical Group, Inc. reported that director Michael A. Rucker received an equity compensation grant of 472 shares of common stock at a value of $26.50 per share. These are restricted shares under the Second Amended and Restated 2008 Incentive Compensation Plan and will vest on May 7, 2027. Following this award, Rucker holds 66,769 shares of Pediatrix common stock directly.

Insider Trade Summary

Grant/Award: 472 shares

Grant/Award 1 txn

Insider Rucker Michael A.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	472	$26.50	$13K

Holdings After Transaction: Common Stock — 66,769 shares (Direct)

Footnotes (1)

1. F1. Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan, reflecting an increase to the annual equity award. Shares will vest on May 7, 2027.

Key Figures

Restricted shares granted: 472 shares Grant valuation price: $26.50 per share Shares held after transaction: 66,769 shares +1 more

4 metrics

Restricted shares granted 472 shares Equity award of common stock to director Michael A. Rucker

Grant valuation price $26.50 per share Reported value per share for the restricted stock grant

Shares held after transaction 66,769 shares Direct holdings of Michael A. Rucker following the grant

Vesting date May 7, 2027 Date when the 472 restricted shares are scheduled to vest

Key Terms

Restricted shares, Second Amended and Restated 2008 Incentive Compensation Plan, vesting

3 terms

Restricted shares financial

"Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

Second Amended and Restated 2008 Incentive Compensation Plan financial

"Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan"

vesting financial

"Shares will vest on May 7, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Pediatrix Medical Group (MD) report for Michael A. Rucker?

Pediatrix Medical Group reported that director Michael A. Rucker received a grant of 472 restricted shares of common stock as part of his annual equity compensation award, increasing his directly held position in the company.

At what price were the 472 Pediatrix (MD) shares granted to Michael A. Rucker?

The 472 restricted shares of Pediatrix common stock were granted at a value of $26.50 per share. This price is used for reporting and compensation valuation purposes, not as a market purchase price on an exchange.

When do Michael A. Rucker’s new restricted Pediatrix (MD) shares vest?

The newly granted 472 restricted shares to director Michael A. Rucker will vest on May 7, 2027. Until vesting, the shares are subject to the terms of Pediatrix’s incentive compensation plan.

How many Pediatrix (MD) shares does Michael A. Rucker hold after this grant?

After the grant of 472 restricted shares, Michael A. Rucker directly holds 66,769 shares of Pediatrix common stock. This figure reflects his ownership position immediately following the reported equity award.

Is the Pediatrix (MD) insider grant to Michael A. Rucker a purchase or an award?

The transaction is an equity award, not an open-market purchase. It is coded as a grant of restricted shares under Pediatrix’s Second Amended and Restated 2008 Incentive Compensation Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/14/2026 - 05:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rucker Michael A.

(Last) (First) (Middle)

1301 CONCORD TERRACE

(Street)

SUNRISE FLORIDA 33323

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Pediatrix Medical Group, Inc. [ MD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/12/2026		A(1)		472	A	$26.5	66,769	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted shares granted pursuant to Issuer's Second Amended and Restated 2008 Incentive Compensation Plan, reflecting an increase to the annual equity award. Shares will vest on May 7, 2027.

	/s/ David Haddock, Attorney-in-Fact	08/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)